Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 18, Number 2—February 2012


Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010

Michael G. BakerComments to Author , Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
Author affiliations: University of Otago, Wellington, New Zealand (M.G. Baker, A. Kvalsvig, J. Zhang, A. Sears, N. Wilson); Institute of Environmental Science and Research, Christchurch, New Zealand (R. Lake)

Main Article

Table 5

Comparsion of ages of patients with campylobacteriosis and GBS, New Zealand, July 1995–December 2008*

Calculation A. Patients with campylobacteriosis
B. Patients hospitalized for campylobacteriosis
C. Patients hospitalized for GBS
D. Patients hospitalized for GBS and campylobacteriosis‡
Age, y Age, y p value for age compared with A§ Age, y p value for age compared with B§ Age, y p value for age compared with C§
Mean 33.7 43.7 <0.0001 48.8 <0.0001 50.3 0.7063
Median 31 41 <0.0001 52.5 <0.0001 54 0.7280

*GBS, Guillain-Barré syndrome.
‡Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
§Means compared with Student t-test medians compared with median 2-sample test.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO